Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000166601 | SCV000217405 | likely benign | Hereditary cancer-predisposing syndrome | 2014-10-24 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000529292 | SCV000628667 | likely benign | Neurofibromatosis, type 1 | 2024-09-04 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000529292 | SCV001479091 | uncertain significance | Neurofibromatosis, type 1 | 2020-10-26 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000166601 | SCV002527625 | likely benign | Hereditary cancer-predisposing syndrome | 2021-05-28 | criteria provided, single submitter | curation |